The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 338:347-354 February 5, 1998 Number 6
NextNext

Effect of a Protective-Ventilation Strategy on Mortality in the Acute Respiratory Distress Syndrome
Marcelo Britto Passos Amato, M.D., Carmen Silvia Valente Barbas, M.D., Denise Machado Medeiros, M.D., Ricardo Borges Magaldi, M.D., Guilherme Paula Schettino, M.D., Geraldo Lorenzi-Filho, M.D., Ronaldo Adib Kairalla, M.D., Daniel Deheinzelin, M.D., Carlos Munoz, M.D., Roselaine Oliveira, M.D., Teresa Yae Takagaki, M.D., and Carlos Roberto Ribeiro Carvalho, M.D.

 

This Article
-Abstract
- PDF

Commentary
-Editorial
 by Hudson, L. D.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background In patients with the acute respiratory distress syndrome, massive alveolar collapse and cyclic lung reopening and overdistention during mechanical ventilation may perpetuate alveolar injury. We determined whether a ventilatory strategy designed to minimize such lung injuries could reduce not only pulmonary complications but also mortality at 28 days in patients with the acute respiratory distress syndrome.

Methods We randomly assigned 53 patients with early acute respiratory distress syndrome (including 28 described previously), all of whom were receiving identical hemodynamic and general support, to conventional or protective mechanical ventilation. Conventional ventilation was based on the strategy of maintaining the lowest positive end-expiratory pressure (PEEP) for acceptable oxygenation, with a tidal volume of 12 ml per kilogram of body weight and normal arterial carbon dioxide levels (35 to 38 mm Hg). Protective ventilation involved end-expiratory pressures above the lower inflection point on the static pressure–volume curve, a tidal volume of less than 6 ml per kilogram, driving pressures of less than 20 cm of water above the PEEP value, permissive hypercapnia, and preferential use of pressure-limited ventilatory modes.

Results After 28 days, 11 of 29 patients (38 percent) in the protective-ventilation group had died, as compared with 17 of 24 (71 percent) in the conventional-ventilation group (P<0.001). The rates of weaning from mechanical ventilation were 66 percent in the protective-ventilation group and 29 percent in the conventional-ventilation group (P = 0.005); the rates of clinical barotrauma were 7 percent and 42 percent, respectively (P = 0.02), despite the use of higher PEEP and mean airway pressures in the protective-ventilation group. The difference in survival to hospital discharge was not significant; 13 of 29 patients (45 percent) in the protective-ventilation group died in the hospital, as compared with 17 of 24 in the conventional-ventilation group (71 percent, P = 0.37).

Conclusions As compared with conventional ventilation, the protective strategy was associated with improved survival at 28 days, a higher rate of weaning from mechanical ventilation, and a lower rate of barotrauma in patients with the acute respiratory distress syndrome. Protective ventilation was not associated with a higher rate of survival to hospital discharge.


Mechanical ventilation can damage the lungs.1,2 Lesions at the alveolar–capillary interface,3 alterations in permeability,4 and edema5,6,7 have repeatedly been shown to occur in animals subjected to adverse patterns of mechanical ventilation.

In clinical practice, however, the "mechanical stretch" caused by conventional ventilation has been found to be detrimental in only a few uncontrolled studies.8,9,10,11 Large variations in the susceptibility of individual animal species12 and the apparent success of mechanical ventilation based on a strategy of using the lowest positive end-expiratory pressure (PEEP) that results in acceptable oxygenation13,14 suggest that the devastating effects observed in animals cannot be easily extrapolated to humans.

We recently demonstrated that mechanical lung protection can be provided in patients with the acute respiratory distress syndrome, resulting in better pulmonary function and higher rates of weaning from the ventilator.15 Briefly, lung protection was based on a strategy of maintaining low inspiratory driving pressures (<20 cm of water above PEEP, with low tidal volumes and preferential use of limited airway pressure over regulation of arterial carbon dioxide levels), with the simultaneous circumvention of alveolar collapse through the use of high PEEP to keep end-expiratory pressures above the lower inflection point (PFLEX) on the static pressure–volume curve of the respiratory system. The nearly maximal alveolar recruitment and aeration accomplished with this strategy were intended to minimize shear stresses in the lung tissue during inspiration.15

We have extended our earlier report15 and evaluated the effect of mechanical lung protection on survival. We hypothesized that preventing the persistent collapse of recruitable units (alveolar units anatomically preserved but requiring high opening pressures for aeration) and reducing cyclic lung reopening and stretch during mechanical breaths would result in lower rates of pulmonary complications and mortality at 28 days in patients with the acute respiratory distress syndrome.

Methods

Study Population

Between December 1990 and July 1995, 53 patients with the acute respiratory distress syndrome were prospectively enrolled in the trial (including 28 described previously15). The hemodynamic data in 48 of the patients during the first seven days of the study have been reported elsewhere.16 The study was conducted in two intensive care units in Brazil: one in São Paulo and one in Porto Alegre. The protocol was approved by the hospitals' medical-ethics committees, and informed consent was obtained from each patient or the patient's next of kin.

Each year during the study period, a total of about 60 patients with the acute respiratory distress syndrome were admitted to the two intensive care units. The criteria for enrollment were an underlying disease process known to be associated with the acute respiratory distress syndrome along with a lung-injury score17 of 2.5 or higher (range, 0 [normal] to 4 [most severe]) plus a pulmonary arterial wedge pressure of less than 16 mm Hg. Confirmation that the tip of the pulmonary arterial catheter was in the area of the lung zone where capillary vessels were patent, transmitting left atrial pressures backward, was assessed with two mechanical maneuvers.5,18 The exclusion criteria (listed in decreasing order of frequency) were previous lung or neuromuscular disease, mechanical ventilation for more than one week, uncontrolled terminal disease, previous barotrauma (pneumothorax, pneumomediastinum, or subcutaneous emphysema), previous lung biopsy or resection, an age of more than 70 years or less than 14 years, uncontrollable and progressive acidosis, signs of intracranial hypertension, and documented coronary insufficiency. The primary diagnoses at enrollment are shown in Table 1.

View this table:
[in this window]
[in a new window]
 
Table 1. Base-Line Characteristics of the Study Groups.

 
Stabilizing Procedures and Randomization

After enrollment, all patients underwent a standardized regimen of ventilatory–hemodynamic procedures for at least 30 minutes (control period), during which time their initial clinical condition was evaluated and stabilized. This regimen consisted of volume-controlled ventilation (tidal volume, 10 ml per kilogram of body weight), a square-wave inspiratory flow of 50 liters per minute, a respiratory rate of 15 cycles per minute, an inspiratory pause of 0.4 second, an inspiratory oxygen fraction of 1.0, PEEP of 5 cm of water or the minimal value necessary to maintain an arterial oxygen saturation of more than 85 percent, 5 percent albumin administered intravenously until the pulmonary arterial wedge pressure was higher than 9 mm Hg, dobutamine administered intravenously in a fixed dose of 5 µg per kilogram per minute, and norepinephrine administered intravenously whenever the mean arterial pressure remained lower than 60 mm Hg (the minimal dose that kept the pressure at or above 60 mm Hg).

After the patient's condition had been stabilized, respiratory, hemodynamic, and laboratory measurements were performed. These data were used for a base-line comparison of the two groups and for calculating the risk of death according to the severity of illness (Table 1). The physiologic data for Acute Physiology and Chronic Health Evaluation (APACHE) II21 scores were collected during the 24-hour period starting at this time. The worst values during this interval, including the control-period measurements, were recorded, except for blood gas and heart-rate values. To avoid the overestimating effects of subsequent permissive hypercapnia on these variables (since respiratory acidosis and tachycardia usually increase the APACHE score), only the control-period measurements of blood gas and heart rate were considered (adjusted APACHE II score).

Subsequently, a bedside procedure was performed to calculate the inspiratory and static pressure–volume curve without disconnecting the ventilator, as described previously.15,22 A well-defined PFLEX (corresponding to an upward shift in the slope of the curve and signaling an increment in lung compliance) could be determined for 49 patients, but the corresponding value was used to adjust PEEP only in the group assigned to protective mechanical ventilation. Since this was the only curve calculated during the protocol, PEEP was then kept constant in this group until the inspiratory oxygen fraction was less than 0.4.15 After determining the pressure–volume curve, we randomly assigned the patients to one of the two groups. Randomization was performed with sealed envelopes and a 1:1 assignment scheme.

General Ventilatory Support

Protective or conventional mechanical ventilation was rigorously maintained until the patient was extubated or died. Each patient was connected to a closed system for aspirating tracheal secretions; the patient remained connected to the ventilator during aspiration, minimizing temporary drops in airway pressure. In both groups, the target partial pressure of arterial oxygen was 80 mm Hg, and the PEEP level was never set below 5 cm of water, even during weaning from the ventilator. The weaning procedure was the same in the two groups: a gradual decrease in the level of pressure support.15 Patients received ventilation exclusively through endotracheal tubes.

Conventional Approach

We sought to maintain an arterial carbon dioxide level of 35 to 38 mm Hg, independent of airway pressures, and an inspiratory oxygen fraction of less than 0.6 with adequate systemic oxygen delivery. To optimize this compromise, we used a stepwise algorithm for PEEP increments.15,16 Other ventilatory settings were as follows: tidal volume, 12 ml per kilogram (volume-cycled assisted or controlled ventilation); square-wave inspiratory flow rate, 50 to 80 liters per minute (adjusted to avoid auto-PEEP, or abnormal gas trapping leading to an elevated end-respiratory pressure); inspiratory pause, 0.4 second; and backup respiratory rate, 10 to 24 cycles per minute (depending on the value for arterial carbon dioxide). In addition to the administration of sedative drugs to keep the patients comfortable, additional doses of sedatives were given to prevent patient-triggered respiratory rates higher than 24 cycles per minute or arterial carbon dioxide values lower than 25 mm Hg.

Protective Approach

The protective approach was intended to prevent alveolar collapse and overdistention, regardless of arterial carbon dioxide levels, and to maintain an "open lung" independently of hemodynamic conditions. The tidal volume was maintained at a level lower than 6 ml per kilogram, with a respiratory rate of less than 30 cycles per minute, even during pressure support. Permissive hypercapnia and continuous infusions of fentanyl and diazepam were used to prevent discomfort and signs of increased respiratory drive. Initial arterial carbon dioxide levels of up to 80 mm Hg were allowed, and slow intravenous sodium bicarbonate infusions (<50 mmol per hour) were permitted if the arterial pH was less than 7.2.

Driving pressures (PPLAT-PEEP, with PPLAT defined as the plateau pressure after the inspiratory pause) and peak airway pressures were kept below 20 and 40 cm of water, respectively. Only pressure-limited modes of ventilation (pressure-controlled inverse-ratio ventilation [ratio of inspiration to expiration, >1] and pressure-support ventilation, both generating constant airway pressure during inspiration) or combined modes (volume-ensured pressure-support ventilation, in which a constant inspiratory pressure is targeted at the same time that a minimal tidal volume is guaranteed23) were used, according to a stepwise algorithm.15

PEEP was preset at 2 cm of water above PFLEX. When auto-PEEP (defined as the difference between alveolar pressures at end expiration and airway pressures) was present, the total PEEP (external PEEP plus auto-PEEP) was considered and adjusted to equal PFLEX plus 2 cm of water. Finally, if a sharp PFLEX could not be determined on the pressure–volume curve, an empirical total-PEEP value of 16 cm of water was used.15 Recruiting maneuvers — aimed at reaerating alveolar units requiring very high opening pressures — were frequently used, especially after inadvertent disconnections from the ventilator. Continuous positive airway pressures of 35 to 40 cm of water were applied for 40 seconds, followed by a careful return to previous PEEP levels. Finally, pressure-controlled inverse-ratio ventilation was used whenever the inspiratory oxygen fraction was higher than 0.5, in order to decrease minute-volume requirements.24

General Support

All patients were monitored with the Swan–Ganz catheter, and a stepwise algorithm for hemodynamic optimization15,16 was used. Measurements of plasma lactate and mixed venous saturation were used to correct imbalances between oxygen transport and demand. The pulmonary-artery wedge pressure never exceeded 15 mm Hg. Procedures for nutritional support, treatment of infections, and renal dialysis (when needed) were the same in both groups.15,16 Corticosteroids were given only to patients with Pneumocystis carinii pneumonia. No patients received immunotherapy. The protocol for sedation was the same for both groups, with only two sedatives prescribed (fentanyl and diazepam) and only one neuromuscular paralyzing drug (pancuronium). Although larger doses (up to 9 mg per day) were used in the protective-ventilation group, continuous infusions of fentanyl were used in both groups to keep the patients comfortable. All patients received ranitidine (50 mg intravenously every eight hours) as prophylaxis against bleeding.

Statistical Analysis

The primary end point was survival at 28 days. The effect of the protective approach was analyzed with a Cox proportional-hazards model, with the base-line adjusted APACHE II score (adjusted risk of death) included as a covariate.

After the first block of 28 patients had been enrolled, a beneficial effect of the protective approach on pulmonary function became evident,15 and we were concerned about the possibility of subjecting the patients to an unnecessary continuation of the protocol.25 Therefore, we performed an interim analysis after each new block of five patients. We estimated that a maximal sample of 58 patients was required, assuming a type I error of 5 percent, a statistical power of 85 percent, and a survival rate in the protective-ventilation group that would be 2.4 times that in the conventional-ventilation group, according to our initial results.15

To counterbalance the increased chance of prematurely stopping the study because of a type I error, we used the conservative correction for multiplicity proposed by Peto et al.26 and Geller and Pocock,27 with a nominal significance level of <0.001 for an interim analysis, if the study was stopped early, and a significance level of <0.04 for the final analysis, if the study was completed.27

The secondary end points were survival to hospital discharge, occurrence of clinically detectable barotrauma, and weaning rate adjusted for APACHE II score (Cox model). Bonferroni's adjustment for multiple comparisons was performed for each secondary end point. All other statistical tests are described below. All P values (two-tailed) were calculated with the BMDP software package (BMDP Statistical Software, version 7.0, Los Angeles).

Results

The study was stopped during the fifth interim analysis, after 53 patients had been enrolled, because of a significant survival difference between the groups (Table 2 and Table 3 and Figure 1). After 28 days, 11 of 29 patients (38 percent) in the protective-ventilation group had died, as compared with 17 of 24 (71 percent) in the conventional-ventilation group (P<0.001). The results were similar when the groups were stratified according to the initial severity of illness or the center where the patient was treated.

View this table:
[in this window]
[in a new window]
 
Table 2. Study Outcomes According to the Intention-to-Treat Analysis.

 
View this table:
[in this window]
[in a new window]
 
Table 3. Base-Line Factors Influencing the Relative Risk of Death at 28 Days.

 

View larger version (5K):
[in this window]
[in a new window]
 
Figure 1. Actuarial 28-Day Survival among 53 Patients with the Acute Respiratory Distress Syndrome Assigned to Protective or Conventional Mechanical Ventilation.

The data are based on an intention-to-treat analysis. The P value indicates the effect of ventilatory treatment as estimated by the Cox regression model, with the risk of death associated with the adjusted base-line score on APACHE II included as a covariate.

 
The difference in weaning rates mirrored the results for survival, with 19 of 29 patients (66 percent) in the protective-ventilation group successfully weaned from the ventilator, as compared with 7 of 24 (29 percent) in the conventional-ventilation group (P = 0.005 after adjustment for multiple comparisons). The rate of clinical barotrauma was also significantly lower in the protective-ventilation group than in the conventional-ventilation group (7 percent vs. 42 percent, P = 0.02 after adjustment for multiple comparisons). The difference in survival to hospital discharge was not significant; 13 of 29 patients in the protective-ventilation group (45 percent) died in the hospital, as compared with 17 of 24 patients in the conventional-ventilation group (71 percent, P = 0.37 after adjustment for multiple comparisons).

Within the first 28 days, the most frequent causes of death were refractory septic shock and progressive respiratory failure (Table 2).15 Fourteen episodes of accidental extubation (usually during repositioning of the patient) occurred in nine patients in the protective-ventilation group, as compared with 10 episodes in seven patients in the conventional-ventilation group. In two of the patients in the protective-ventilation group and one in the conventional-ventilation group, irreversible cardiac events followed these episodes. Although successfully extubated (at >48 hours), four patients in the protective-ventilation group died before hospital discharge: one from massive hemothorax with arterial rupture during attempts at central venous cannulation (on day 7), one from diffuse gastrointestinal bleeding (on day 23), one from intracerebral nocardiosis with brain edema (on day 11), and one from a new episode of nosocomial pneumonia followed by refractory septic shock (on day 68). Except for the episode of arterial rupture, no iatrogenic event related to central lines occurred after study entry.

The values for the respiratory variables measured during the first week of the study are shown in Table 4. The objectives of ventilatory support were achieved in 48 of the 53 patients. Although the mean respiratory values suggest good adherence to the protocol, there were minor protocol violations in the care of four patients in the protective-ventilation group and one patient in the conventional-ventilation group. In the patient in the conventional-ventilation group, a tidal volume of 7 ml per kilogram was inadvertently used for 12 hours. Among the violations in the protective-ventilation group, there was an inadvertent use of a tidal volume higher than 7 ml per kilogram during a period of eight hours, a PEEP prematurely reduced in disregard of the protocol, use of antibiotics in disregard of the protocol, and a previous pneumothorax detected during a careful review of radiographs. The exclusion of these five patients from the analysis of mortality had little effect on the mortality rate associated with the protective-ventilation approach (relative risk of death, 0.14 [95 percent confidence interval, 0.05 to 0.38], as compared with 0.19 [95 percent confidence interval, 0.08 to 0.47]). The protective-ventilation approach had significant benefits with regard to oxygenation and lung compliance.

View this table:
[in this window]
[in a new window]
 
Table 4. Respiratory Values during the First Week of Mechanical Ventilation.

 
Table 3 shows the results of univariate and multivariate analyses of mortality at 28 days according to base-line factors (data collected during the control period before randomization). The APACHE II scores and the ventilatory treatment were the only significant factors. These were the two covariates that had been included a priori in the final multivariate Cox regression model.

Discussion

We found that in a group of patients with severe acute respiratory distress syndrome, the protective approach to mechanical ventilation improved the survival rate at 28 days and the weaning rate but not the rate of survival to hospital discharge. The incidence of barotrauma was significantly lower in the protective-ventilation group than in the conventional-ventilation group, despite the use of higher PEEP levels and higher mean airway pressures.

The complexity of the procedures in this study precluded the use of a protocol in which the investigators were unaware of the treatment assignments. Nevertheless, we believe that the stringent algorithms used for infectious problems, hemodynamic values, nutrition, sedation, dialysis, and general care15 were sufficient to minimize additional bias due to differences in the management of nonrespiratory problems. We demonstrated in a previous analysis that we were able to accomplish the planned hemodynamic goals in most patients in both groups.16 Finally, it is difficult to ascribe the better outcome in the protective-ventilation group to uncontrolled or unrecognized factors, since our staff was much more used to the conventional approach. In fact, a greater number of fatal iatrogenic accidents occurred in the protective-ventilation group than in the conventional-ventilation group. Considering the small size of the study, the conservative nature of Bonferroni's statistical adjustment,27 and the severity of base-line disease in the patients (which was responsible for many of the late deaths), the failure to detect a significant difference in survival to hospital discharge was not surprising.

Despite the use of an appropriate rule for early termination of the study during all interim analyses,26,27 the estimates of relative risk shown in Table 3 may be imprecise. The corrections proposed for multiple sequential analysis can properly control the overall type I error, but they cannot prevent associated distortions of the magnitude of the treatment effect caused by early termination or the small sample.28

Since the effect of the protective-ventilation strategy on survival was observed in the context of many concomitant maneuvers (permissive hypercapnia, lower peak and driving pressures, higher PEEP, a tidal volume of less than 6 ml per kilogram, and so forth), we performed a pooled "retrospective" analysis to determine the key combination of ventilatory variables responsible for the ventilatory treatment effect on mortality at 28 days (data not shown). When the treatment assignment was removed from the Cox mortality model, there were three significant prognostic factors: the APACHE II score, the mean PEEP used during the first 36 hours (with a protective effect indicated by a coefficient of -0.15), and the driving pressures (PPLAT-PEEP) during the first 36 hours (with a deleterious effect of high driving pressures indicated by a coefficient of 0.06). All other respiratory variables were of secondary importance. Higher PEEP values (preferentially above the PFLEX value) and lower driving pressures were independently associated with better survival. High initial PEEP values appeared to be beneficial, even when the PPLAT value increased, as long as the driving pressure did not change disproportionately.

The strong protective effect associated with a high PEEP value is consistent with recent experimental data,7,29,30,31,32,33 and the benefit seems to be more pronounced than the deleterious effect of high distending pressures.7,29,30 Had we not used high PEEP levels (>PFLEX), the results might have been very different, with the isolated reduction in PPLAT potentially causing reabsorption atelectasis, loss of alveolar surface, and hypoxemia in some patients.

Recent evidence suggests that the minimization of ventilator-induced lung injury may have important systemic benefits, decreasing the release of proinflammatory mediators,34,35,36 the dissemination of infections,37,38,39 and possible complications related to air embolism.40,41 In addition to preventing progressive respiratory failure, the protective-ventilation approach may be associated with these mechanisms.

Despite the use of higher PEEP values (up to 24 cm of water) and higher mean airway pressures, there was a lower incidence of barotrauma in the protective-ventilation group. The protective-ventilation approach may thus not only improve pulmonary function and oxygenation but also reduce clinically apparent alveolar damage. Another study suggested a protective effect of PEEP against clinical barotrauma.42 The paucity of data in favor of this concept may be explained by the correlation normally found between PEEP and peak pressures.43,44 In our study, however, the use of high PEEP levels did not necessarily result in high peak or plateau pressures.

Supported by the Laboratório de Investigação Médica, Hospital das Clínicas, University of São Paulo, and Intermed Equipamento Médico Hospitalar.

We are indebted to Drs. Eduardo C. Meyer, Mauro R. Tucci, Pedro Caruso, Ivany A.L. Schettino, Cristiane Hoelz, Elnara Negri, Chin An Lin, Eloisa A. Silva, Vasco Moskovitz, Laerte Pastore, Fabio Gomes, Sergio Demarzo, Cristiane Morais, Eduardo de Oliveira Fernandes, Marcia Xavier Barreto, Marco Ferreira, Mauro Kaufmann, Luis Alexandre Borges, Jorge Höher, Jairo Othero, Luis A. Azambuja, Gilberto Friedman, Michelle Grunauer, and all the residents working in our units during the study period for their dedication and collaboration in providing care to the patients; to Dr. Rosangela Santoro de Souza Amato for her assistance in the preparation of the manuscript; to Intermed Equipamento Médico Hospitalar and Siemens–Elema for technical support; and especially to Dr. John J. Marini for his stimulating discussions and helpful comments.


Source Information

From the Respiratory Intensive Care Unit, Pulmonary Division, Hospital das Clínicas, University of São Paulo (M.B.P.A., C.S.V.B., D.M.M., R.B.M., G.P.P.S., G.L.-F., R.A.K., D.D., T.Y.T., C.R.R.C.); and the General Intensive Care Unit, Santa Casa de Misericórdia, Porto Alegre (C.M., R.O.) — both in Brazil. Presented in part at the International Conference of the American Lung Association and the American Thoracic Society, New Orleans, May 10–15, 1996.

Address reprint requests to Dr. Amato at 135 Rua Dr. Joel Lagos, CEP 05344-000 São Paulo, Brazil.

References

  1. Snyder JV, Froese A. Respirator lung. In: Snyder JV, Pinsky MR, eds. Oxygen transport in the critically ill. Chicago: Year Book Medical Publishers, 1987:358-73. 
  2. Marini JJ. Ventilation of the acute respiratory distress syndrome: looking for Mr. Goodmode. Anesthesiology 1994;80:972-975. [Medline]
  3. Fu Z, Costello ML, Tsukimoto K, et al. High lung volume increases stress failure in pulmonary capillaries. J Appl Physiol 1992;73:123-133. [Free Full Text]
  4. Carlton DP, Cummings JJ, Scheerer RG, Poulain FR, Bland RD. Lung overexpansion increases pulmonary microvascular protein permeability in young lambs. J Appl Physiol 1990;69:577-583. [Free Full Text]
  5. Parker JC, Hernandez LA, Longenecker GL, Peevy K, Johnson W. Lung edema caused by high peak inspiratory pressures in dogs: role of increased microvascular filtration pressure and permeability. Am Rev Respir Dis 1990;142:321-328. [Medline]
  6. Tsuno K, Prato P, Kolobow T. Acute lung injury from mechanical ventilation at moderately high airway pressures. J Appl Physiol 1990;69:956-961. [Free Full Text]
  7. Dreyfuss D, Saumon G. Role of tidal volume, FRC, and end-inspiratory volume in the development of pulmonary edema following mechanical ventilation. Am Rev Respir Dis 1993;148:1194-1203. [Medline]
  8. Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990;16:372-377. [CrossRef][Medline]
  9. Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 1994;22:1568-1578. [Medline]
  10. Gattinoni L, Pesenti A, Mascheroni D, et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 1986;256:881-886. [Abstract]
  11. Lee PC, Helsmoortel CM, Cohn SM, Fink MP. Are low tidal volumes safe? Chest 1990;97:430-434. [Free Full Text]
  12. Mathieu-Costello O, Willford DC, Fu Z, Garden RM, West JB. Pulmonary capillaries are more resistant to stress failure in dogs than in rabbits. J Appl Physiol 1995;79:908-917. [Free Full Text]
  13. Albert RK. Least PEEP: primum non nocere. Chest 1985;87:2-4. [Free Full Text]
  14. Petty TL. The use, abuse, and mystique of positive end-expiratory pressure. Am Rev Respir Dis 1988;138:475-478. [Medline]
  15. Amato MBP, Barbas CSV, Medeiros DM, et al. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome: a prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med 1995;152:1835-1846. [Abstract]
  16. Carvalho CRR, Barbas CSV, Medeiros DM, et al. Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS. Am J Respir Crit Care Med 1997;156:1458-1466. [Free Full Text]
  17. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720-723. [Erratum, Rev Respir Dis 1989;139:1065.] [Medline]
  18. Teboul JL, Besbes M, Andrivet P, et al. A bedside index assessing the reliability of pulmonary artery occlusion pressure measurements during mechanical ventilation with positive end-expiratory pressure. J Crit Care 1992;7:22-29. [CrossRef]
  19. Yeung HC, Lu MW, Martinez EG, Puri VK. Critical Care Scoring System -- new concept based on hemodynamic data. Crit Care Med 1990;18:1347-1352. [Medline]
  20. Smith PEM, Gordon IJ. An index to predict outcome in adult respiratory distress syndrome. Intensive Care Med 1986;12:86-89. [Medline]
  21. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Apache II: a severity of disease classification system. Crit Care Med 1985;13:818-829. [Medline]
  22. Amato MBP, Barbas CSV, Meyer EC, Grunauer MA, Magaldi RB, Carvalho CRR. Setting the "best PEEP" in ARDS: limitations of choosing the PEEP according to the "best compliance." Am J Respir Crit Care Med 1995;151:Suppl:A550-A550.abstract 
  23. Amato MBP, Barbas CSV, Bonassa J, Saldiva PHN, Zin WA, Carvalho CRR. Volume-assured pressure support ventilation (VAPSV): a new approach for reducing muscle workload during acute respiratory failure. Chest 1992;102:1225-1234. [Free Full Text]
  24. Gattinoni L, Mascheroni D, Borelli M, Basilico E, Pesenti A. Ventilation in severe ARDS: inverted ratio ventilation and CO2 removal. In: Lemaire F, ed. Mechanical ventilation. Berlin, Germany: Springer-Verlag, 1991:129-45.
  25. Pocock SJ. When to stop a clinical trial. BMJ 1992;305:235-240.
  26. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976;34:585-612. [Medline]
  27. Geller NL, Pocock SJ. Interim analysis in randomized clinical trials: ramifications and guidelines for practitioners. Biometrics 1987;43:213-223. [CrossRef][Medline]
  28. Pocock SJ, Hughes MD. Estimation issues in clinical trials and overviews. Stat Med 1990;9:657-671. [Medline]
  29. Muscedere JG, Mullen JBM, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994;149:1327-1334. [Abstract]
  30. Bshouty Z, Ali J, Younes M. Effect of tidal volume and PEEP on rate of edema formation in in situ perfused canine lobes. J Appl Physiol 1988;64:1900-1907. [Free Full Text]
  31. Sandhar BK, Niblett DJ, Argiras EP, Dunnill MS, Sykes MK. Effects of positive end-expiratory pressure on hyaline membrane formation in a rabbit model of the neonatal respiratory distress syndrome. Intensive Care Med 1988;14:538-546. [CrossRef][Medline]
  32. Argiras EP, Blakeley CR, Dunnill MS, Otremski S, Sykes MK. High PEEP decreases hyaline membrane formation in surfactant deficient lungs. Br J Anaesth 1987;59:1278-1285. [Free Full Text]
  33. Wyszogrodski I, Kyei-Aboagye K, Taeusch HW Jr, Avery ME. Surfactant inactivation by hyperventilation: conservation by end-expiratory pressure. J Appl Physiol 1975;38:461-466. [Free Full Text]
  34. Edmonds HL Jr, Spohr RW, Finnegan RF, et al. Indomethacin pretreatment in continuous positive-pressure ventilation. Crit Care Med 1981;9:524-529. [Medline]
  35. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997;99:944-952. [Medline]
  36. Sugiura M, McCulloch PR, Wren S, Dawson RH, Froese AB. Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung. J Appl Physiol 1994;77:1355-1365. [Free Full Text]
  37. Tilson MD, Bunke MC, Smith GJ, et al. Quantitative bacteriology and pathology of the lung in experimental Pseudomonas pneumonia treated with positive end-expiratory pressure (PEEP). Surgery 1977;82:133-140. [Medline]
  38. Johanson WG Jr, Higuchi JH, Woods DE, Gomez P, Coalson JJ. Dissemination of Pseudomonas aeruginosa during lung infection in hamsters: role of oxygen-induced lung injury. Am Rev Respir Dis 1985;132:358-361. [Medline]
  39. Nahum A, Hoyt J, McKibben A, et al. Effect of mechanical ventilation strategy on E. coli pneumonia in dogs. Am J Respir Crit Care Med 1996;153:Suppl:A531-A531.abstract 
  40. Marini JJ, Culver BH. Systemic gas embolism complicating mechanical ventilation in the adult respiratory distress syndrome. Ann Intern Med 1989;110:699-703.
  41. Gregory GA, Tooley WH. Gas embolism in hyaline-membrane disease. N Engl J Med 1970;282:1141-1142.
  42. Mathru M, Rao TLK, Venus B. Ventilator-induced barotrauma in controlled mechanical ventilation versus intermittent mandatory ventilation. Crit Care Med 1983;11:359-361. [Medline]
  43. Petersen GW, Baier H. Incidence of pulmonary barotrauma in a medical ICU. Crit Care Med 1983;11:67-69. [Medline]
  44. Zwillich CW, Pierson DJ, Creagh CE, Sutton FD, Schatz E, Petty TL. Complications of assisted ventilation: a prospective study of 354 consecutive episodes. Am J Med 1974;57:161-170. [CrossRef][Medline]

 

This Article
-Abstract
- PDF

Commentary
-Editorial
 by Hudson, L. D.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation

Related Letters:

Protective Ventilation for the Acute Respiratory Distress Syndrome
Chiche J.-D., Brunet F., Lamy M., Kacmarek R., Parsons P. E., Matthay M., Manning H. L., Shapira M. Y., Sviri S., Linton D. M., Weg J. G., Anzueto A., Amato M. B.P., Barbas C. S.V., Carvalho C. R.R., Stewart T. E., Meade M. O., Slutsky A. S.
Extract | Full Text  
N Engl J Med 1998; 339:196-199, Jul 16, 1998. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.